Needham & Company has aggressively lowered its price target for Trade Desk (TTD) to $32.00, joining a wave of analysts reassessing the company's premium valuation. Despite recent revenue beats, institutional sell-offs and concerns over long-term growth sustainability are driving a significant market re-rating.
Waystar (NASDAQ: WAY) is navigating a divided Wall Street as Needham & Company lowered its price target to $33.00, citing potential growth headwinds. This move contrasts with Truist Financial's $38.00 valuation, highlighting a widening gap in expectations for the healthcare payment platform's market penetration.
Waystar (NASDAQ: WAY) is facing a divergent outlook from major analysts as Needham & Company LLC lowered its price target to $33.00, while Truist Financial established a more optimistic $38.00 target. These updates come as the healthcare payments SaaS provider navigates a complex post-IPO landscape characterized by shifting provider spending patterns.